Anpario (LON:ANP) Shares Pass Below 200 Day Moving Average - Should You Sell?

Key Points

• Shares of Anpario plc (LON:ANP) fell below its 200-day moving average, trading at GBX 377.50 ($5.10) compared to the average of GBX 421.20 ($5.69).
• The stock has a market cap of £64.91 million and is noted for a low debt-to-equity ratio of 0.10.
• Shore Capital maintains a "house stock" rating on Anpario, indicating potential for growth despite recent stock performance.

Anpario plc (LON:ANP - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 421.20 ($5.66) and traded as low as GBX 377.50 ($5.07). Anpario shares last traded at GBX 377.50 ($5.07), with a volume of 20,725 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Shore Capital reissued a "house stock" rating on shares of Anpario in a research note on Monday, March 31st.

Anpario Stock Up 0.6%

The stock has a market cap of £65.25 million, a P/E ratio of 21.12 and a beta of 0.58. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10. The firm has a 50 day simple moving average of GBX 422.07 and a 200-day simple moving average of GBX 421.55.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.